PBI18 ESTIMATION OF THE HEALTHCARE RESOURCE UTILIZATION (HCRU) COSTS IN PATIENTS WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA RECEIVING TISAGENLECLEUCEL: A MICRO-COSTING STUDY IN THE UK AND FRANCE
Nov 1, 2019, 00:00
10.1016/j.jval.2019.09.122
https://www.valueinhealthjournal.com/article/S1098-3015(19)32500-8/fulltext
Title :
PBI18 ESTIMATION OF THE HEALTHCARE RESOURCE UTILIZATION (HCRU) COSTS IN PATIENTS WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA RECEIVING TISAGENLECLEUCEL: A MICRO-COSTING STUDY IN THE UK AND FRANCE
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)32500-8&doi=10.1016/j.jval.2019.09.122
First page :
Section Title :
Open access? :
No
Section Order :
10078